Operating Lease, Liability, Current in USD of Inhibrx Biosciences, Inc. from Q4 2023 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Present value of lessee's discounted obligation for lease payments from operating lease, classified as current.
Summary
Inhibrx Biosciences, Inc. quarterly Operating Lease, Liability, Current history and change rate from Q4 2023 to Q3 2025.
  • Inhibrx Biosciences, Inc. Operating Lease, Liability, Current for the quarter ending September 30, 2025 was $2.25M, a 22.5% increase year-over-year.
Operating Lease, Liability, Current, Quarterly (USD)
Operating Lease, Liability, Current, YoY Quarterly Change (%)

Inhibrx Biosciences, Inc. Quarterly Operating Lease, Liability, Current (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $2.25M +$412K +22.5% Sep 30, 2025 10-Q 2025-11-14
Q2 2025 $2.17M -$2K -0.09% Jun 30, 2025 10-Q 2025-08-13
Q1 2025 $1.97M Mar 31, 2025 10-Q 2025-05-14
Q4 2024 $1.6M -$468K -22.7% Dec 31, 2024 10-Q 2025-11-14
Q3 2024 $1.84M Sep 30, 2024 10-Q 2024-11-14
Q2 2024 $2.17M Jun 30, 2024 10-Q 2024-08-13
Q4 2023 $2.06M Dec 31, 2023 10-K 2025-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.